Research
Metabolic tumor volume trajectory during bridging and association with outcomes after CAR T infusion in large B-cell lymphoma
Nature ·
The Brief
- The study examines how metabolic tumor volume changes during bridging therapy before CAR T infusion in large B-cell lymphoma.
- The article links metabolic tumor volume trajectory during bridging to outcomes after CAR T infusion.
- Only the title and metadata of the source were available; no summary or detailed results were provided.
Why it matters
Tracking tumor burden during bridging therapy may help clinicians anticipate how patients with large B-cell lymphoma respond to CAR T treatment.
Who’s affected
- clinicians and researchers treating large B-cell lymphoma
- patients receiving CAR T-cell therapy